Glass M R, Shaw R W, Williams J W, Butt W R, Logan-Edwards R, London D R
Clin Endocrinol (Oxf). 1976 Sep;5(5):521-30. doi: 10.1111/j.1365-2265.1976.tb01981.x.
The effect of the administration of oestradiol benzoate and of progesterone on the subsequent response to LHRH has been investigated in women with hyperprolactinaemia. There was an amplification in the release of LH in four out of ten patients and of FSH in one out of ten patients at 44 h after the administration of 2-5 mg oestradiol benzoate. The average amount of LH released before and after oestrogen did not change, but there was a significant decrease in the amount of FSH released. There was no correlation between the LH released and the oestradiol concentration in serum at the time of the LHRH tests but there was a negative correlation between the FSH released and the oestradiol concentration (r = 0-507;P less than 0-05). These results contrast with those obtained in normal subjects in the follicular phase of the cycle when there is a positive correlation of oestrogen concentrations and the amount of LH and FSH released. As in normal subjects, however, a significant suppression of basal FSH concentrations, persisting until 44 h, was produced by the oestrogen (P less than 0-01). Seven out of eleven patients showed an amplification of LH response and six out of eleven an FSH response 20 h after the administration of 25 mg progesterone. The mean amplifications are not significantly different from those of normal subjects tested in the early follicular phase of the cycle, but are significantly less than those tested in the mid follicular phase of the cycle (LH P less than 0-001; FSH P less than 0-01). This may be related to the serum concentrations of oestradiol which in patients with hyperprolactinaemia are significantly less than those found in the mid follicular phase of the cycle (P less than 0-05). These results indicate that in women with hyperprolactinaemia oestrogen negative feedback, necessary for cycle initiation, is normal: failure of ovulation may be related to failure of positive feedback to oestroen. Oestrogen-negative feedback is unopposed and this may explain the follicullar development and lack of oestrogen in the mid-follicular phase.
已对患有高泌乳素血症的女性给予苯甲酸雌二醇和孕酮后,其随后对促黄体生成素释放激素(LHRH)的反应进行了研究。在给予2 - 5毫克苯甲酸雌二醇后44小时,十名患者中有四名患者的促黄体生成素(LH)释放增加,十名患者中有一名患者的促卵泡生成素(FSH)释放增加。雌激素给药前后LH的平均释放量没有变化,但FSH的释放量显著减少。在LHRH测试时,释放的LH与血清雌二醇浓度之间没有相关性,但释放的FSH与雌二醇浓度之间存在负相关(r = 0 - 507;P小于0 - 05)。这些结果与在月经周期卵泡期的正常受试者中获得的结果形成对比,在正常受试者中,雌激素浓度与释放的LH和FSH量呈正相关。然而,与正常受试者一样,雌激素导致基础FSH浓度显著降低,这种降低持续至44小时(P小于0 - 01)。在给予25毫克孕酮后20小时,十一名患者中有七名患者的LH反应增强,十一名患者中有六名患者的FSH反应增强。平均增强幅度与在月经周期早期卵泡期测试的正常受试者的增强幅度没有显著差异,但显著小于在月经周期中期卵泡期测试的正常受试者的增强幅度(LH P小于0 - 001;FSH P小于0 - 01)。这可能与高泌乳素血症患者血清雌二醇浓度显著低于月经周期中期卵泡期的浓度有关(P小于0 - 05)。这些结果表明,在患有高泌乳素血症的女性中,启动月经周期所必需的雌激素负反馈是正常的:排卵失败可能与对雌激素的正反馈失败有关。雌激素负反馈未受到拮抗,这可能解释了卵泡期的卵泡发育以及卵泡中期雌激素缺乏的现象。